Discover 1,131 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
With many research studies being conducted across the state, Indiana provides opportunities for both healthy volunteers interested in paid studies and individuals with specific health needs. Research centers in Indianapolis, Fort Wayne, and South Bend are actively recruiting participants, granting access to advanced treatments and innovative healthcare.
Filter
1
Filter results
Results: 1,131
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Westbury NY, New York NY, Lancaster PA, York PA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361510
Phase 3, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
for
Agitation Associated With Alzheimer's Disease Dementia
Location: Bennington VT, Brooklyn NY, New York NY, Peterborough,
Sponsor: Exciva GmbH
Sex: All
Age: 55 - 70+
Code: NCT07284472
Phase 2, Phase 3, Recruiting
Caring for Caregivers of Individuals With Alzheimer's Disease
for
Intervention Group, Treatment as Usual
Location: Indianapolis IN
Sponsor: Indiana University
Sex: All
Age: 18 - 70+
Code: NCT07486037
Recruiting
Zimmer Biomet-RibFix Titan
for
Rib Fracture, Rib Fracture Multiple
Location: Indianapolis IN
Sponsor: Zimmer Biomet
Sex: All
Age: 18+
Code: NCT07485829
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis
Location: Worcester MA, New York NY, Boca Raton FL, Maitland FL,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07299019
Phase 3, Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
for
Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR),
Location: Westbrook ME, Toronto, Indianapolis IN, Nashville TN,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07403721
Phase 1, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, White Plains NY, Schenectady NY, Montreal,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
for
Ovarian Neoplasms, Ovarian Cancer
Location: Scarborough ME, Providence RI, Chicoutimi, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07318558
Phase 3, Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Boston MA, New Hyde Park NY, New York NY, Hackensack NJ,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase 3, Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for
Follicular Lymphoma (FL)
Location: Saint John, Boston MA, Quebec, Stony Brook NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091254
Phase 3, Recruiting
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
for
Relapsed Small Cell Lung Cancer,
Location: Philadelphia PA, Salisbury NC, Pittsburgh PA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 18+
Code: NCT06681220
Phase 1, Phase 2, Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Bryn Mawr PA, Syracuse NY, North Charleston SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2